GRI Bio, Inc. (GRI) Balance Sheet

NASDAQ: GRIAssets, liabilities, debt and equity over 8 years.

GRI balance sheet, 2025

December 31, 2025 · U.S. dollars

$8.7M assets = $2.7M liabilities + $6.0M equity

What it owns$8.7MCash & ST investments: $8.2M (95.0%)Cash & ST investments$8.2M · 95%Other current: $363,000 (4.2%)PP&E: $74,000 (0.9%)=How it is financed$8.7MCurrent liabilities: $2.6M (30.5%)Current liabilities$2.6M · 30%Other LT liabilities: $15,000 (0.2%)Shareholders’ equity: $6.0M (69.3%)Shareholders’ equity$6.0M · 69%

Both columns are drawn to the same scale: what GRI owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GRI financial health

Current ratio3.25
Comfortable · current assets cover current liabilities 3.25×
Debt / equity0.01
Low leverage · $0.01 of debt for each $1 of equity
Equity / assets69.3%
Equity-funded · of assets funded by shareholders
Cash / debt11,590.1%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GRI balance sheet trends, 2018–2025

GRI Bio, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$639,2312018$8.7M2025+45.1%/yr
Total liabilities$486,2922018$2.7M2025+27.5%/yr
Shareholders’ equity$152,9392018$6.0M2025+68.9%/yr
Cash & short-term investments$612,6522018$8.2M2025+44.9%/yr
Total debt$340,0212019$71,0002025−23.0%/yr
Net cash (debt)$3.5M2019$8.2M2025+$4.7M
Working capital$151,3472018$5.9M2025+$5.8M
Current ratio1.3120183.252025+1.94
Debt / equity0.1120190.012025−0.09

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GRI assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GRI liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GRI debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GRI balance sheet

GRI Bio, Inc. annual balance sheet
20252024202320222021202020192018
Assets
Cash & short-term investments$8.2M$5.0M$1.8M$9,000$90,000$109,000$3.8M$612,652
Cash & equivalents$8.2M$5.0M$1.8M$9,000$90,000$109,000$3.8M$612,652
Short-term investments————$3.8M———
Receivables$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0
Other current assets$363,000$587,000$1.1M$303,000$6,000$565,000$100,860$24,987
Total current assets$8.6M$5.6M$2.9M$312,000$96,000$674,000$3.9M$637,639
Property, plant & equipment (net)$74,000$124,000$22,000$71,000$117,000$281,000$353,902$1,592
Goodwill & intangible assets$0$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0
Other non-current assets$0$0$0$0$5,000$0$0$0
Total assets$8.7M$5.7M$3.0M$383,000$218,000$955,000$4.3M$639,231
Liabilities
Accounts payable$1.8M$897,000$1.4M$1.3M$57,000$1.2M$246,329$286,613
Short-term debt$56,000$48,000$14,000$659,000$3.5M$152,000$85,665—
Deferred revenue———$5,000$62,000$81,000——
Total current liabilities$2.6M$1.6M$2.7M$2.0M$4.9M$2.2M$807,498$486,292
Long-term debt$0$0$0$0$0$0$0$0
Lease obligations$71,000$119,000$14,000$71,000$114,000———
Other long-term liabilities$15,000$71,000$0$14,000$67,000$183,999$254,356$0
Total liabilities$2.7M$1.7M$2.7M$2.0M$4.9M$2.4M$1.1M$486,292
Shareholders' equity
Common stock & paid-in capital———$1,000$352,000$227,000$18,025$11,250
Retained earnings (deficit)−$51.7M−$39.7M−$31.5M−$18.5M−$15.3M−$12.6M−$7.8M−$4.3M
Accumulated other comprehensive income————−$2,000———
Total shareholders' equity$6.0M$4.0M$259,000−$1.6M−$4.7M−$1.5M$3.2M$152,939
Key figures
Total debt$71,000$119,000$14,000$673,000$3.6M$336,000$340,021—
Net cash (debt)$8.2M$4.9M$1.8M−$664,000−$3.5M−$227,000$3.5M—
Working capital$5.9M$4.0M$237,000−$1.7M−$4.8M−$1.6M$3.1M$151,347
Tangible book value$6.0M$4.0M$259,000−$1.6M−$4.7M−$1.5M$3.2M$152,939
Book value per share—$0.82——————
Shares outstanding—4.9M——————
Current ratio3.253.431.090.160.020.304.861.31
Quick ratio3.113.070.670.000.020.054.731.26
Debt / equity0.010.030.05———0.11—
Equity / assets69.3%70.3%8.8%−424.3%−2,167.0%−152.3%75.2%23.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.

GRI financial position

At the end of fiscal 2025 (December 31, 2025), GRI Bio had total assets of $8.7 million (up 51.0% from a year earlier), total liabilities of $2.7 million and shareholders' equity of $6.0 million. It held $8.2 million in cash and short-term investments against $0.1 million of debt, a net cash position of $8.2 million. Its current ratio was 3.25. In the latest quarter (ended June 30, 2026) total assets were $11.4 million and equity $10.3 million.

Related: GRI income statement, GRI cash flow statement, GRI key metrics. See the GRI stock overview for the latest quote and news.

GRI balance sheet FAQ

What are GRI Bio's total assets?

GRI Bio reported total assets of $8.7 million at the end of fiscal 2025 (December 31, 2025), compared with $5.7 million a year earlier.

How much debt does GRI Bio have?

GRI Bio had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.01.

How much cash does GRI Bio have?

GRI Bio held $8.2 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $8.2 million.

What is GRI Bio's book value?

GRI Bio's shareholders' equity (book value) was $6.0 million at the end of fiscal 2025.

What is GRI Bio's current ratio?

GRI Bio had current assets of $8.6 million and current liabilities of $2.6 million, a current ratio of 3.25 (it can cover its short-term obligations).

Biotechnology: balance sheet